Abstract
Stimuli-responsive nano-carrier systems have been pursued with great interest due to their advantages such as controlled drug release, improved pharmacokinetics and pharmacodynamics, and reduced side effects of the drugs. These nano-carriers have potential to accumulate effectively into the tumor due to “enhanced permeability and retention” (EPR) effect and advancements in surface science further allow active targeting strategies. Development of some such nano-vectors is driven by hallmark characteristics of tumor microenvironment such as hypoxia, acidic pH, and reducing biologically-relevant milieu. This chapter highlights the features of self-regulated internally controlled redox-responsive nano-carrier systems, opportunities presented by them and the promise these “intelligent” delivery vectors offer in improving existing cancer therapeutic approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ABC:
-
ATP binding casette
- cGLP:
-
Current Good Laboratory Practices
- cGMP:
-
Current Good Manufacturing Practices
- CNC:
-
Cellulose nanocrystals
- CPP-SA:
-
1,3-bis(carboxyphenoxy) propane-sebacic acid
- DOPE:
-
Dioleoyl phosphatidylethanolamine
- DTT:
-
Dithiothreitol
- ECM:
-
Extracellular matrix
- EGFR:
-
Epidermal growth factor receptor
- EPR:
-
Enhanced permeability and retention
- FDA:
-
Food and Drug Administration
- GSH:
-
Glutathione
- HIF:
-
Hypoxia inducible factor
- MMP:
-
Matrix metalloproteinase
- PDMAEMA:
-
Poly(2-(dimethylamino) ethyl methacrylate)
- PEG:
-
Poly(ethylene glycol)
- TMBQ:
-
Trimethyl-locked benzoquinone
- VCAM:
-
Vascular cell adhesion molecule
- VEGF:
-
Vascular endothelial growth factor
References
Arunachalam B, Phan UT, Geuze HJ, Cresswell P (2000) Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 97(2):745–750
Cairns R, Papandreou I, Denko N (2006) Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4(2):61–70
Carol Ward SPL, Mullen P, Harris AL, Harrison DJ, Claudiu IHK, Supuran T (2013) New strategies for targeting the hypoxic tumour microenvironment in breast cancer. Cancer Treat Rev 39:171–179
Cheng R, Meng F, Deng C, Klok HA, Zhong Z (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34(14):3647–3657
Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62(12):3387–3394
Dai J, Lin S, Cheng D, Zou S, Shuai X (2011) Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed Engl 50(40):9404–9408
Danhier F, Feron O, Preat V (2010) To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148(2):135–146
Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10(1):9–22
Ganta S, Devalapally H, Shahiwala A, Amiji M (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 126(3):187–204
Giri S, Trewyn BG, Stellmaker MP, Lin VS (2005) Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl 44(32):5038–5044
Han Y, Li J, Zan M, Luo S, Ge Z, Liu S (2014) Redox-responsive core cross-linked micelles based on cypate and cisplatin prodrugs-conjugated block copolymers for synergistic photothermal–chemotherapy of cancer. Polym Chem 5(11):3707–3718
Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276
Hu H, Yuan W, Liu FS, Cheng G, Xu FJ, Ma J (2015a) Redox-responsive polycation-functionalized cotton cellulose nanocrystals for effective cancer treatment. ACS Appl Mater Interfaces 7(16):8942–8951
Hu K, Zhou H, Liu Y, Liu Z, Liu J, Tang J, Li J, Zhang J, Sheng W, Zhao Y, Wu Y, Chen C (2015b) Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells. Nanoscale 7(18):8607–8618
Huo M, Yuan J, Tao L, Wei Y (2014) Redox-responsive polymers for drug delivery: from molecular design to applications. Polym Chem 5(5):1519–1528
Iyer AK, Singh A, Ganta S, Amiji MM (2013) Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev 65(13–14):1784–1802
Kumagai Y, Toi M, Inoue H (2002) Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research. Lancet Oncol 3(10):604–610
Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VS (2003) A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 125(15):4451–4459
Ma N, Li Y, Xu H, Wang Z, Zhang X (2010) Dual redox responsive assemblies formed from diselenide block copolymers. J Am Chem Soc 132(2):442–443
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387–6392
Meng F, Hennink WE, Zhong Z (2009) Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 30(12):2180–2198
Ong W, Yang Y, Cruciano AC, McCarley RL (2008) Redox-triggered contents release from liposomes. J Am Chem Soc 130(44):14739–14744
Romero-Garcia S, Lopez-Gonzalez JS, Baez-Viveros JL, Aguilar-Cazares D, Prado-Garcia H (2011) Tumor cell metabolism: an integral view. Cancer Biol Ther 12(11):939–948
Shao Y, Shi C, Xu G, Guo D, Luo J (2014) Photo and redox dual responsive reversibly cross-linked nanocarrier for efficient tumor-targeted drug delivery. ACS Appl Mater Interfaces 6(13):10381–10392
Singh A, Xu J, Mattheolabakis G, Amiji M (2015) EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Nanomedicine 12(3):589–600
Wang H, Tang L, Tu C, Song Z, Yin Q, Yin L, Zhang Z, Cheng J (2013) Redox-responsive, core-cross-linked micelles capable of on-demand, concurrent drug release and structure disassembly. Biomacromolecules 14(10):3706–3712
Wang J, Yang G, Guo X, Tang Z, Zhong Z, Zhou S (2014a) Redox-responsive polyanhydride micelles for cancer therapy. Biomaterials 35(9):3080–3090
Wang S, Zhang S, Liu J, Liu Z, Su L, Wang H, Chang J (2014b) pH- and reduction-responsive polymeric lipid vesicles for enhanced tumor cellular internalization and triggered drug release. ACS Appl Mater Interfaces 6(13):10706–10713
Xiao D, Jia HZ, Ma N, Zhuo RX, Zhang XZ (2015) A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery. Nanoscale 7(22):10071–10077
Xu J, Singh A, Amiji MM (2014) Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer 14:75
Yang P, Gai S, Lin J (2012) Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 41(9):3679–3698
Zhang S, Zhao Y (2011) Controlled release from cleavable polymerized liposomes upon redox and pH stimulation. Bioconjug Chem 22(4):523–528
Zhuang Y, Su Y, Peng Y, Wang D, Deng H, Xi X, Zhu X, Lu Y (2014) Facile fabrication of redox-responsive thiol-containing drug delivery system via RAFT polymerization. Biomacromolecules 15(4):1408–1418
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Singh, A., Tran, TH., Amiji, M.M. (2016). Redox-Responsive Nano-Delivery Systems for Cancer Therapy. In: Prokop, A., Weissig, V. (eds) Intracellular Delivery III. Fundamental Biomedical Technologies. Springer, Cham. https://doi.org/10.1007/978-3-319-43525-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-43525-1_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43523-7
Online ISBN: 978-3-319-43525-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)